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Tuesday, February 5, 2013 451a6.5 significantly (p<0.05) reduced filament velocity by 47 and 95%, respec-
tively. In addition, filament velocity was depressed at any given submaximal
Ca2þ level with the effect significantly more pronounced at pH 6.5 vs 6.8. How-
ever, the pCa50 increased significantly (p<0.05) when the pH was reduced from
7.4 to 6.8 (6.7650.07 vs. 7.6250.14) but was not significantly affected at pH
6.5 (6.6250.82). This suggests a complex relationship between pH and Ca2þ-
sensitivity. The addition of Pi had no effect on filament velocity at pH 7.4 but
significantly reversed the acidosis-induced depression in velocity at both pH
6.8 and 6.5, at every level of Ca2þ from pCa 7.0 to pCa 5.0. The addition of
Pi also increased the pCa50 at pH 6.5 from 6.6250.82 to 7.7450.20. The ef-
fects of these ions on regulated thin filament velocity are significantly more
pronounced than those observed with unregulated actin filaments (Debold
et al., 2011); therefore, we are now attempting to identify the structural regions
responsible by assessing the functional impact of structural alterations to key
regions of Tn.
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We have used stopped-flow fluorescence to measure the acceleration of disso-
ciation of hydrolysis products, Pi and deoxymantADP (mdADP), from
myosinS1-mdADP-Pi and myosinS1-mdADP by native cardiac thin filaments
(TF) at near physiological ionic strength (0.1M KAc). Although the rate con-
stants of the product dissociation steps cannot be measured at this ionic
strength, there is a linear dependence of the kobs of product (Pr = mdADP or
mdADP-Pi) dissociation (TF þ M-Pr4 TF-M-Pr/ TF-M þ Pr) on [TF],
which can be used to determine the dependence of the apparent second
order rate constant upon the ligands calcium and rigor myosin. The second
order rate constant of the dependence of the kobs of Pi dissociation from
myosinS1-mdADP-Pi on thin filament (actin subunit) concentration is:
2x103 M1s1 (no rigor myosin, pCa>8), 5.9x104 M1s1 (rigor myosin,
pCa>8), 1.3x105 M1s1 (no rigor myosin, pCa<4), and 1.8x105 M1s1
(rigor myosin, pCa<4). The second order rate constant of the dependence of
the kobs of mdADP dissociation from myosinS1-mADP on thin filament con-
centration is: 4.2x104 M1s1 (no rigor myosin, pCa>8), 2.3x105 M1s1
(rigor myosin, pCa>8), 6.2x105 M1s1 (no rigor myosin, pCa<4), and
1.2x106 M1s1 (rigor myosin, pCa<4). Thus, neither calcium nor rigor myo-
sin is sufficient to maximally activate thin filament acceleration of product dis-
sociation on its own. Full activation requires both calcium and rigor myosin to
be bound to the thin filament. These results are (i) similar to data previously
obtained at low ionic strength; (ii) inconsistent with models which predict
that rigor myosin fully activates the thin filament and (iii) support a mechanism
of thin filament regulation in which the principal regulated step of the hydroly-
sis cycle is phosphate dissociation from actomyosin-ADP-Pi.
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Increases in muscle nitric-oxide (NO) production can be buffered by reaction
with intracellular glutathione, forming S-nitrosoglutathione (GSNO). GSNO
has been shown to S-nitrosylate Cys thiols of cardiac contractile proteins
in vivo and in vitro, but effects on maximal force, thin-filament Ca2þ sensitivity
and actomyosin ATPase activity are unknown. Here, we analyzed the targets of
S-nitrosylation in mouse cardiac contractile proteins, and examined the effects
of these modifications on function in myocytes and skinned cardiac myofibrils.
S-Nitrosylation and denitrosylation were detected using resin-assisted capture
(SNO-RAC) and targets for S-nitrosylation were identified by quantitative
LC-MS/MS. Isolated cardiomyocytes treated with S-nitrosocysteine (CysNO,
500mM, 10min) showed an increase in total protein-SNO, followed by progres-
sive denitrosylation (30-60min with CysNO). At 10min, CysNO dose-dependently increased S-nitrosylation of specific Cys thiols in myosin heavy
chain, actin, TnC, TnI, myosin-binding protein C and other muscle proteins.
Myofibril thin-filament Ca2þ sensitivity decreased (P<0.05) after in-vitro treat-
ment with pharmacological GSNO concentrations (1, 10, 100 mM), but maxi-
mum force did not change (P>0.05). Loss of Ca2þ sensitivity was partially
reversed by the denitrosation agent, ascorbate. Relaxation kinetics of skinned
fibers, as measured by flash photolysis, were also significantly reduced
by100mMGSNO (k1,15.33 to 11.68/s; k2 2.33 to 0.87/s; fit to double exponen-
tial). Maximal myofibrillar ATPase activity (pCa 5.0) was also dose-
dependently inhibited (8, 15, 30%) by 50, 100 and 500mM GSNO, an effect
that was reversed by ascorbate. The findings suggest that S-nitrosylation of reg-
ulatory Cys thiol(s) can reversibly modulate cardiac muscle contraction and
may be able to protect the heart by reducing myosin ATPase demand without
affecting the maximal force of contraction.
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The effect of h-caldesmon (h-CaD) on smooth muscle contractility was exam-
ined by force measurements on tissues isolated from wild-type (WT) and h-
CaD-null (KO) mice. Both aorta and tail arteries from KO mice relaxed
more slowly than that from WT animals. The force decay of beta-escin-
permeabilized, kinase-inhibited tissues under pCa>9 was best fitted with
a two-exponential process. We found that the apparently slower relaxation
for the KO samples was not due to lower rate constants, but rather, was because
of increased amplitude of the slower component of the decay. To search for an
explanation for the observed relaxation kinetics, we drew some lessons from
the work done on striated muscles. Muscle relaxation involves two major
events: crossbridge detachment and change of the thin filament from active
to inactive state. The latter occurs first, corresponding to the initial lag phase,
followed by the rapid force decay, the crossbridge detachment. In smooth mus-
cle, the lag phase is ascribed to myosin dephosphorylation, but it may also in-
clude the filament state change, i.e., CaD-tropomyosin moving to a position on
actin filaments that hinders myosin binding. This ‘‘off-position’’ is under strain,
because the dephosphorylated crossbridges are still attached. Assuming that
there are two possible positions for CaD-tropomyosin to occupy, one displacing
the bound myosin more promptly than the other, the crossbridge would detach
at two different rates, resulting in the observed biphasic decay. Our data then
suggest that when h-CaD is absent, fewer tropomyosin molecules are at the
blocking position. Thus, the return of smooth muscle tropomyosin to the proper
inhibitory position upon relaxation needs help from h-CaD. In striated muscle
the movement of tropomyosin was shown to be facilitated by troponin subunits.
CaD may play a troponin-like role in smooth muscle both structurally and
functionally.
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It is generally accepted that dephosphorylation of regulatory light chain (RLC)
induces the interactions between the two heads of smooth muscle myosin (Sm)
and between the head and the tail, thus inhibiting the motor activity, and phos-
phorylation of RLC interrupts above interactions, thus reversing the inhibition
and stimulating the motor activity to maximal value. Thus it is predicted that
Sm subfragment-1 (S1) containing only one head without the tail is fully active.
However, no solid evident so far supports this prediction, although early studies
showed that S1 produced by limited protease treatment is partially active. Here
we produced a number of Sm truncations with various length of the tail. The
stability of double-headed structure of Sm is dependent on the length of the
coiled-coil tail. The Sm truncations with coiled-coil longer than 214 amino
acids form stable double-headed structure (stable HMM), those with coiled-
coil shorter than 179 amino acids form unstable double headed structure (unsta-
ble HMM), and that without coiled-coil, i.e. S1, is completely single-headed.
Phosphorylation of RLC regulates the motor activity of stable HMM com-
pletely, regulates that of unstable HMM partially, and does not regulate that
of S1. Unexpectedly, the actin-activated ATPase activity of S1, either unphos-
phorylated or phosphorylated, is higher than that of unphosphorylated stable
HMM but less than 10% of that of phosphorylated stable HMM. The actin-
activated ATPase activities of unphosphorylated Sm truncations increase
with the shortening of the coiled-coil tail, and that of phosphorylated Sm trun-
cations decrease with the shortening of the coiled-coil tail. These results indi-
cate that the stable double-headed structure is critical not only for the inhibited
452a Tuesday, February 5, 2013state of unphosphorylated Sm, but also for the fully activated state of phosphor-
ylated Sm.
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Inter-molecular interactions between two smooth muscle myosin heads have
been observed using chemical cross linking and visualized by electron micros-
copy. In order to probe the nature of the phosphorylation-dependent head-head
interactions, we performed Hydrogen-Deuterium exchange electrospray ioni-
zation mass spectrometry (HDX-MS) on phosphorylated and unphosphorylated
smooth muscle heavy mero myosin (HMM) from chicken gizzard. HDX rates
are determined by solvent accesibility and the strength of hydrogen bonding
and thus are a good fingerprint of intra- and intermolecular structural changes.
The observed decrease in deuterium uptake upon phosphorylation in the coiled-
coil and the hinge region of the heavy chain (residues 864-877), is consistent
with the unraveling of the myosin dimer at the hinge. Unexpectedly, we have
observed phosphorylation dependent changes in the regulatory light chain
(RLC 58-69), which are not implicated in the RLC-RLC or RLC-heavy chain
interface. No changes were observed for N-terminal region of RLC that was
postulated to undergo major secondary structure changes, or in the heavy chain
actin binding site (residues 397-437) , or any of the residues that form the head-
head interface in the EMmodel of Wendt & Taylor. This latter finding indicates
that the interaction between the heads is probably transient in solution, or in the
unlikely case, interacting heads constitute a very small fraction of total protein.
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Smooth muscle is distributed in many organs, and plays a critical role in main-
taining blood pressure in vasculature and airflow in airway and malfunction of
the smooth muscle causes severe health problems. Smooth muscle contraction
is primarily regulated by myosin light chain (MLC) phosphorylation, which is
regulated by both Ca2þ dependent and Ca2þ independent pathways. Recent
studies have revealed that MLC phosphatase (MLCP) plays a key role in the
latter mechanism. MLCP activity is regulated by the phosphorylation of
MYPT1, a myosin binding regulatory subunit of MLCP, and CPI-17,
a MLCP specific inhibitor protein. Here we found novel signaling mechanism
of controlling smooth muscle contraction induced by agonists. We found that
agonist stimulation significantly activates Rac1 activity in smooth muscle,
and the inhibition of Rac markedly decreases agonist induced force of arterial
smooth muscle. Moreover, introduction of active Rac1 activates smooth muscle
contraction, while dominant-negative Rac1 attenuates the agonist-induced con-
traction. Rac1 dependent change in contraction is accompanied by the change
in MLC phosphorylation, MYPT1 phosphorylation and CPI-17 hosphorylation.
Rac inhibitors activatedMLCP activity, but not MLCK activity, suggesting that
Rac1 dependent change in MLC phosphorylation is due to the change in MLCP
activity. Rac inhibitors did not change RhoA and ROCK activities, unlike
RhoA pathway. Interestingly, Rac1 inhibition induced the change in
MYPT1/CPI-17 phosphatase activity. The result suggests that Rac1 dependent
change in MYPT1/CPI-17 phosphorylation is due to the change in the phospha-
tase activity rather than the kinase activites that phopshorylate MYPT1 and
CPI-17 such as ROCK. These results suggest that agonist induced change in
MLCP activity in smooth muscle is concertedly regulated by RhoA pathway
that modulates ROCK and Rac1 pathway that regulates MYPT1/CPI-17
phosphatases.
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Vertebrate smooth muscle contraction is regulated by phosphorylation of the
myosin regulatory light chains. EM studies of smooth muscle myosin mole-
cules suggest that in the dephosphorylated state, activity is switched off by
asymmetric interactions between the two myosin heads, in which the
‘‘blocked’’ head is thought to be unable to bind to actin, while the ‘‘free’’head has its ATPase activity inhibited. Comparative sequence analysis and mo-
lecular modeling suggest that the head interaction may be stabilized by charge
attraction between D748 in the converter domain of the free head and K368 of
the blocked head, and between R406 or K416 of the blocked head and E169 of
the free head (Jung et al., MBC, 2008). To test these possibilities, we investi-
gated the structure of expressed smooth muscle myosin and heavy meromyosin
in which the charges at some of these sites was neutralized or reversed. While
most of the mutants showed no obvious change in structure compared with wild
type, HMM with charge reversal at both 368 and 406 showed fewer molecules
with interacting heads when observed by metal shadowing. This was supported
by a decrease in sedimentation coefficient (determined by analytical ultracen-
trifugation) and an increase in actin-activated ATPase activity of the mutant.
Whole myosin with the same mutations formed filaments more readily than
wild type, also consistent with these results. These observations suggest that
charge interactions involving K368 and R406 play a role in stabilizing the
head-head interaction of the inactive state. Interestingly, mutation of R403 in
cardiac myosin (R406 in smooth muscle) increases motor activity of myosin
and causes familial hypertrophic cardiomyopathy. Our results suggest that
this could be in part a result of changes in head interaction.
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We are using fluorescence microscopy to characterize the interaction of single
active MLCK molecules with smooth muscle myosin (SMM) filaments and
acto-SMM bundles in an in vitro: model system to determine the mechanism
by which MLCK phosphorylates SMM. Since ATP is required for the SMM
ATPase and the MLCK kinase activity, this requires unphosphorylated SMM
filaments that are stable in the presence of ATP, a condition that normally
causes disassembly. We have prepared and characterized modified SMM fila-
ments for this study. They are 1) covalently labeled with NHS-Rhodamine
for ease of imaging, 2) lightly cross-linked with EDC on the heavy chain so
they are stable to ATP-induced disassembly, 3) similar to native SMM fila-
ments in length, 4) fully regulated by phosphorylation measured by acto-
SMM ATPase activity, and the ability to move actin in an in vitro motility as-
say, and 5) able to dissociate from actin in an [ATP]-dependent manner. Inter-
estingly, these modified SMM filaments are capable of bundling actin filaments
in the presence of ATP, calmodulin (CaM), and Ca2þ; conditions that are suf-
ficient for MLCK to phosphorylate SMM. SMMfilaments preferentially bind to
actin bundles rather than single actin filaments, and as ATP is titrated into
a preparation of acto-SMM bundles, they dissociate leaving short actin fila-
ments which are predominantly bound to SMM filaments. We have imaged
the interaction of single quantum dot-labeled MLCK (QD-MLCK) molecules
with these SMMfilaments and acto-SMM bundles using total internal reflection
fluorescence (TIRF) microscopy to visualize single QD-MLCK. We observed
QD-MLCK colocalizing with SMM filaments and acto-SMM bundles and will
characterize the QD-MLCK interaction with both proteins in the presence of
ATP before and after activation of MLCK by Ca2þ-CaM.
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Smooth muscle (SM) hyper-contractility is central to the pathophysiology of
several diseases, including asthma. Inflammatory cells and/or their products
may alter the expression of contractile proteins, thereby enhancing SM me-
chanics. The goal of the current study was to characterize the maximum un-
loaded shortening velocity (Vmax), stress (force/cross sectional area), and
contractile protein expression of Brown Norway (BN) rat airway SM in the
presence of activated CD4þ T cells. T cells from OVA-sensitized BN rats
were co-cultured with tracheal rings for 24h. The SM strips were then mounted
in a mechanical testing apparatus, equilibrated and supramaximally stimulated
with methacholine. A significant increase in Vmax (mean5S.E.) (0.1550.01 l/s
for control, 0.2950.02 l/s for sensitized, p=0.0012) was observed whereas no
significant changes in stress (84.5513.9 kPa for control, 107.854.8 kPa for
sensitized) were seen. Western blot analysis showed that levels of the (þ)insert
myosin heavy chain isoform and myosin light chain kinase (MLCK) were sig-
nificantly increased. To determine whether contact between T cells and SM
cells is required for this enhanced contractility, CD4þT cells were placed in
the upper chamber of a transwell, separated by a membrane from the muscle
